麥當勞(MCD.US)收購凱雷(CG.US)中港澳麥當勞少數股權
麥當勞(MCD.US)周一表示已同意收購凱雷集團(CG.US)與中信資本控股旗下的信宸資本部分股權,該合夥企業於中國、香港和澳門經營和管理麥當勞業務。
麥當勞表示,中信及凱雷於麥當勞中國業務將保留其控股權,但麥當勞總公司於信宸資本持股比例將從20%提高至48%。
麥當勞總裁兼執行長Chris Kempczinski於聲明中稱,自建立合夥企業以來,與中信集團和凱雷的策略合作在擴大麥當勞在該地區的業務方面取得巨大成功,中國現在是其第二大市場;自2017年以來,麥當勞餐廳數量增加一倍達到超過5,500間。
麥當勞預計將於2024年第一季完成交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.